Cargando…
A small-molecule Skp1 inhibitor elicits cell death by p53-dependent mechanism
Skp1 overexpression promotes tumor growth, whereas reduced Skp1 activity is also linked with genomic instability and neoplastic transformation. This highlights the need to gain better understanding of Skp1 biology in cancer settings. To this context, potent and cellularly active small-molecule Skp1...
Autores principales: | Hussain, Muzammal, Lu, Yongzhi, Tariq, Muqddas, Jiang, Hao, Shu, Yahai, Luo, Shuang, Zhu, Qiang, Zhang, Jiancun, Liu, Jinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249674/ https://www.ncbi.nlm.nih.gov/pubmed/35789855 http://dx.doi.org/10.1016/j.isci.2022.104591 |
Ejemplares similares
-
Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
por: Liu, Yong-Qiang, et al.
Publicado: (2015) -
Skp2 and Skp2B team up against Rb and p53
por: Germain, Doris
Publicado: (2011) -
Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
por: Hu, Kaizhao, et al.
Publicado: (2021) -
Publisher Correction: Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
por: Hu, Kaizhao, et al.
Publicado: (2021) -
Affinity of Skp to OmpC revealed by single-molecule detection
por: Pan, Sichen, et al.
Publicado: (2020)